Assessment of the clinical effectiveness and safety of immune checkpoint inhibitors for glioblastoma: A systematic review
Glioblastoma (GBM) is a malignant primary brain tumor which is commonly found in humans. Conventional therapeutic approaches for GBM offer only a short median overall survival (MOS), thereby accentuating its poor clinical outcome. Despite the promising potential shown by use of immune checkpoint inh...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2023-12-01
|
| Series: | Romanian Journal of Neurology |
| Subjects: | |
| Online Access: | https://rjn.com.ro/articles/2023.4/RJN_2023_4_Art-02.pdf |